Early Switch in Moderate ARDS (SWITCH-ARDS)
Early Switch to Assisted Ventilation in Patients With Moderate ARDS: a Physiological Study
The optimal timing for transition from controlled to assisted mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) remains uncertain. Excessive spontaneous respiratory effort may promote injurious transpulmonary pressure swings and heterogeneous regional ventilation, whereas unnecessary prolongation of controlled ventilation may increase sedation exposure and diaphragmatic dysfunction.
This prospective, single-center physiological interventional study will enroll mechanically ventilated adults with ARDS and a PaO₂/FiO₂ ratio >100 and ≤200 mmHg, measured during PEEP=5 cmH2O, who are receiving controlled mechanical ventilation. Participants will undergo a protocolized 30-minute transition from controlled to assisted mechanical ventilation after reduction of sedation sufficient to allow spontaneous respiratory activity.
Respiratory effort and drive, airway and esophageal pressures, respiratory flow, respiratory mechanics, gas exchange, and regional ventilation measured by electrical impedance tomography will be assessed before and during the transition. Participants will subsequently be followed for 48 hours to determine whether assisted ventilation can be maintained without return to fully controlled mechanical ventilation.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Participants meeting eligibility criteria will initially remain on their clinically prescribed controlled mechanical ventilation. Sedation will be gradually reduced to permit the reappearance of spontaneous respiratory activity while avoiding clinically significant agitation or patient-ventilator dyssynchrony. Once spontaneous respiratory activity is present, participants will be transitioned to assisted mechanical ventilation. Positive end-expiratory pressure will be maintained at the pre-transition level, which will have been titrated with the use of esophageal manometry so as to achieve an end-expiratory trans-pulmonary pressure above 0 cmH2O, and inspired oxygen fraction will remain unchanged whenever clinically feasible. Inspiratory assistance will be titrated to maintain protective targets: esophageal pressure swings= 3-15 cmH2O (diaphragm protective) and transpulmonary pressure swings < 15-20 cmH2O (lung protective).
The physiological transition trial will last 30 minutes. Continuous recordings of airway pressure, esophageal pressure, respiratory flow, and electrical impedance tomography will be obtained. Respiratory drive will additionally be assessed using airway occlusion pressure at 100 milliseconds (P0.1).
Three prespecified analysis periods will be used: T0, the final 5 minutes during controlled ventilation before transition; T1, the first 5 minutes of assisted ventilation; and T2, minutes 25-30 of assisted ventilation.
Electrical impedance tomography analyses will include regional distribution of tidal ventilation, global inhomogeneity index, end-expiratory lung impedance, ventral-to-dorsal ventilation distribution, center of ventilation, and occurrence or magnitude of pendelluft. Respiratory mechanics analyses will include esophageal pressure swing, pressure-time product of the esophageal pressure, transpulmonary pressure, respiratory system elastance, chest-wall elastance, and lung elastance.
The transition trial will be stopped if prespecified clinical intolerance or safety criteria occur. Participants who do not tolerate the trial will be returned to controlled ventilation according to clinical requirements.
After completion of the 30-minute trial, participants will be followed for 48 hours. Successful transition will be defined as maintenance of assisted mechanical ventilation without the need to return to fully controlled mechanical ventilation during this period.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Apostolos - Alkiviadis Menis, MD, PhD
- Numero di telefono: +30 2413501280
- Email: menis.ap.alk@proton.me
Backup dei contatti dello studio
- Nome: Demosthenes Makris, MD, PhD
- Numero di telefono: +30 2413501280
- Email: dimomakris@med.uth.gr
Luoghi di studio
-
-
-
Larissa, Grecia
- Reclutamento
- Critical Care Department, University Hospital of Larisa
-
Contatto:
- Apostolos Menis, MD, PhD
- Numero di telefono: +30 2413 501278
- Email: menis.ap.alk@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Patients with ARDS of severe to moderate severity (100<PaO2/FiO2<200 mmHg).
Descrizione
Inclusion Criteria:
- Age ≥18 years
- Endotracheally intubated and receiving invasive mechanical ventilation
- Meets diagnostic criteria for acute respiratory distress syndrome
- PaO₂/FiO₂ ratio >100 and ≤200 mmHg
- Receiving controlled mechanical ventilation immediately before the transition trial
Exclusion Criteria:
- Implanted electrical cardiac or other device incompatible with electrical impedance tomography
- Thoracic drains, extensive dressings, or other factors preventing appropriate EIT belt placement
- Contraindication to placement of an esophageal balloon catheter
- Active neuromuscular blockade at initiation of the transition trial
- Significant hemodynamic instability
- Any clinical condition for which reduction of sedation or transition to assisted ventilation is considered unsafe by the treating physician
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: PROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Experimental: Protocolized Transition to Assisted Mechanical Ventilation
|
Participants receiving controlled mechanical ventilation will undergo gradual reduction of sedation to permit spontaneous respiratory activity, followed by a 30-minute transition to assisted mechanical ventilation. PEEP will remain at the pre-transition value and FiO₂ will remain unchanged whenever clinically feasible. Inspiratory assistance will be titrated to maintain tidal volume at approximately 6-8 mL/kg predicted body weight. Physiological measurements will be recorded continuously, and the procedure will be terminated if prespecified intolerance or safety criteria occur. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Lasso di tempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. We will measure respiratory rate (breaths per minute). |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Lasso di tempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. The measured variables will include the lung elastance, the chest wall elastance and the total respiratory system elastance (all measured in cmH₂O/L). |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Lasso di tempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. The measured variables will include the transpulmonary pressure, which is measured in cmH₂O. During the baseline measurement both statics and dynamics measurements will be calculated, whereas during the assisted phase the investigator will include only the dynamic measurements. |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Lasso di tempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. We will measure tidal volume (mLs). |
During the first thirty minutes of assisted ventilation.
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Lasso di tempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the variation in the global inhomogeneity index derived by using electrical impedance tomography. |
During the first thirty minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Lasso di tempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the end-expiratory lung impedance, EELI, which is measured in ohms. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Lasso di tempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the ventral to dorsal ratio using the electrical impedance tomography. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Lasso di tempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the variation in the pendelluft phenomenon using the impedance amplitude values. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in respiratory effort between successful and failed transition to assisted ventilation
Lasso di tempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the differences in esophageal pressure swings, ΔPes in cmH₂O, between the beginning of the transition phase and at the final 5 minutes of the 30-minute trial. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in respiratory effort between successful and failed transition to assisted ventilation.
Lasso di tempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the differences in the esophageal pressure-time product measured in cmH₂O⋅s/min, between the beginning of the transition phase and at the final 5 minutes of the 30-minute trial. |
During the first 30-minutes of assisted ventilation.
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Investigatore principale: Apostolos - Alkiviadis Menis, MD, PhD, General University Hospital of Larisa, University of Thessaly
- Direttore dello studio: Makris, MD, PhD, General University Hospital of Larisa, University of Thessaly
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- SWITCH_MODERATE_ARDS
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .